We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Children With Cystic Fibrosis Are Infected With Multiple Subpopulations of Mycobacterium abscessus With Different Antimicrobial Resistance Profiles.
- Authors
Shaw, Liam P; Doyle, Ronan M; Kavaliunaite, Ema; Spencer, Helen; Balloux, Francois; Dixon, Garth; Harris, Kathryn A
- Abstract
Background Children with cystic fibrosis (CF) can develop life-threatening infections of Mycobacterium abscessus. These present a significant clinical challenge, particularly when the strains involved are resistant to antibiotics. Recent evidence of within-patient subclones of M. abscessus in adults with CF suggests the possibility that within-patient diversity may be relevant for the treatment of pediatric CF patients. Methods We performed whole-genome sequencing (WGS) on 32 isolates of M. abscessus that were taken from multiple body sites of 2 patients with CF who were undergoing treatment at Great Ormond Street Hospital, United Kingdom, in 2015. Results We found evidence of extensive diversity within patients over time. A clustering analysis of single nucleotide variants revealed that each patient harbored multiple subpopulations, which were differentially abundant between sputum, lung samples, chest wounds, and pleural fluid. The sputum isolates did not reflect the overall within-patient diversity and did not allow for the detection of subclones with mutations previously associated with macrolide resistance (rrl 2058/2059). Some variants were present at intermediate frequencies before the lung transplants. The time of the transplants coincided with extensive variation, suggesting that this event is particularly disruptive for the microbial community, but the transplants did not clear the M. abscessus infections and both patients died as a result of these infections. Conclusions Isolates of M. abscessus from sputum do not always reflect the entire diversity present within the patient, which can include subclones with differing antimicrobial resistance profiles. An awareness of this phenotypic variability, with the sampling of multiple body sites in conjunction with WGS, may be necessary to ensure the best treatment for this vulnerable patient group.
- Subjects
UNITED Kingdom; MORTALITY risk factors; LUNG analysis; CLUSTER analysis (Statistics); CYSTIC fibrosis; DRUG resistance in microorganisms; GENETIC polymorphisms; HEALTH facilities; LUNG transplantation; MACROLIDE antibiotics; GENETIC mutation; MYCOBACTERIAL diseases; MYCOBACTERIUM; PLEURAL effusions; RISK assessment; SPUTUM; TRANSPLANTATION of organs, tissues, etc.; PHENOTYPES; CHEST (Anatomy); SEQUENCE analysis; DISEASE risk factors; CHILDREN
- Publication
Clinical Infectious Diseases, 2019, Vol 69, Issue 10, p1678
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciz069